Navigation Links
Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 13th

PARSIPPANY, N.J., April 29, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), an integrated global specialty pharmaceutical company, announced today that the Company will conduct a live webcast of its 2011 Annual Meeting of Stockholders on Friday May 13, 2011 beginning at 9:00 AM Eastern Daylight Time. As part of the meeting, Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business.

The webcast can be accessed on Watson Pharmaceuticals' Investor Relations Website or directly at An archived version of the webcast will be available for 30 days beginning several hours after the live presentation concludes.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at

(Logo: Eisenhaur(862) 261-8141Media:Charlie Mayr(862) 261-8030

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Watson First Quarter 2011 Net Revenue Increases to $877 Million
2. New Life Agency Adds Watson to Join Walgreens on The Fertility Pharmacy Care Card for Fertility Medication
3. Watson Confirms Welchol® Patent Challenge
4. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
5. Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings
6. Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
7. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
8. Watson Confirms OxyContin® Patent Challenge
9. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
10. Cephalon Wins FENTORA Patent Suit Against Watson
11. Watson Launches Generic Famvir®
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):